-+ 0.00%
-+ 0.00%
-+ 0.00%

Barrington Research Downgrades Surmodics to Underperform

Benzinga·11/14/2025 18:07:26
Listen to the news
Barrington Research analyst Michael Petusky downgrades Surmodics (NASDAQ:SRDX) from Market Perform to Underperform.